Testing effectiveness (Phase 2)Active Not RecruitingNCT07020377
What this trial is testing
Dapagliflozin in Nonalcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus Patients (T2DM).
Who this might be right for
Diabetes MellitusNon Alcholic Fatty Liver Disease
Amira Bisher,PhD 60